
    
      On the basis of the eligibility criteria, patients is assigned by the enrolling physician to
      one of two strata. The first stratum includes patients with moderate drug-resistant
      hypertension, defined by the Joint National Committee VII and ESH/ESC guidelines as office BP
      ≥ 140/90 mm Hg and <160/100 mm Hg. The second stratum includes patients with drug-resistant
      hypertension, defined by office BP ≥ 160/100 mm Hg.
    
  